Billions of catalogs find their way into America's mailboxes every year. A new online service aims to slow down that flood of glossy paper. Lenora Chu reports.
The federal government is looking at a staffing crunch as a huge wave of employees readies to retire in the next five years. It could be a great opportunity for older workers. Danielle Karson reports.
The big-and-tall market in menswear is worth $5 billion and growing everyday. Jennifer Collins takes a look at a company that's trying to tackle this big market through some unlikely characters.
GOP isn't a ticker symbol on the New York Stock Exchange and Democrats aren't listed on the Nasdaq, but prediction markets' trading on presidential candidates' chances are seen as trendy oracles of the campaign's outcome. Commentator Dan Drezner cautions, however, they have a mixed record.
These days, when television networks talk about chasing viewers, they mean it literally. Movie theaters, grocery stores, gas stations, sports events…. If you're there, they want to be there. Mary-Rose Abraham reports.
Republican and Democratic leaders huddled on Capitol Hill today and emerged vowing to craft a bipartisan economic stimulus package. But, as much as politicians love to spend money and cut taxes, there's a fight over both. John Dimsdale reports.
All around the world, stock markets are indicating an imminent U.S. recession. Doug Krizner talks to the Times of London's Nick Haysel about the U.K.'s reaction to overnight market drops.
Congress may be tempted to threaten China with tariffs unless they raise the value of the yuan, but commentator Robert Reich says this sort of move misses the real source of the problem.
The drug Vytorin has been a multibillion-dollar blockbuster — although it hasn't exactly been the cholesterol buster it was supposed to be. Commentator and physician Dr. Stefan Kertesz says it's a cautionary tale about the process of approving new pharmaceuticals.
